Cloning and expression of human 5-HT(4S) receptors. Effect of receptor density on their coupling to adenylyl cyclase

NeuroReport

Volumn 8, Issue 15, 1997, Pages 3189-3196

  Claeysen, Sylvie ^a   Faye, Patrick ^a   Sebben, Michèle ^a   Lemaire, Stéphanie ^b   Bockaert, Joël ^a   Dumuis, Aline ^a  

^a INSERM   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

Coupling efficiency; Human 5 HT4 receptor; Receptor density

Indexed keywords

RENZAPRIDE; SEROTONIN 4 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SEROTONIN BRAIN LEVEL;

EID: 0030828512     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199710200-00002     Document Type: Article

References (28)

1. Dunmis A, Bouhelal R, Sebben M et al. Mol. Pharmacol. 34, 880-887 (1988).
2. Eglen R, Wong EHF, Dumuis A et al. Trends Pharmacol Sci 16, 391-398 (1995).
3. Bockaert J, Fozard J, Dumuis A et al. Trends Pharmacol Sci 13, 141-145 (1992).
4. Letty S, Child R, Pantaloni A et al. Neuropharmacology 36, 681-687 (1997).
5. Marchetti-Gauthier E, Roman FS, Dumuis A et al. Neuropharmacology 36, 697-706 (1997).
6. Hegde S and Eglen RM. FASEB J 10, 1-10 (1996).
7. Gerald C, Adham N, Kao H-T et al. EMBO J 14, 2806-2815 (1995).
8. Claeysen S, Sebben M, Journot L et al. FEBS Lett 398, 19-25 (1996).
9. Kaumann AJ, Sanders L, Brown AM et al. Naunyn-Schmiedeberg's Arch Pharmacol 344, 150-159 (1991).
10. Ouadid H, Seguin J, Dumuis A et al. Mol Pharmacol 41, 346-351 (1992).
11. Dumuis A, Sebben M and Bockaert J. Naunyn-Schmiedeberg's Arch Pharmacol 340, 403-410 (1989).
12. Schall TJ, Lewis M, Koller KJ et al. Cell 61, 361-370 (1990).
13. Ansanay H, Sebben M, Bockaert J et al. Eur J Pharmacol 298, 165-174 (1996).
14. Munson PJ and Rodbard D. Anal Biochem 107, 220-239 (1980).
15. Waeber C, Sebben M, Grossman C et al. NeuroReport 4, 1239-1242 (1993).
16. Bockaert J. Curr Opin Neurobiol 1, 32-42 (1991).
17. Oliviera L, Paiva ACM, Sander C et al. Trends Pharmacol Sci 15, 170-172 (1994).
18. O'Dowd BF, Hnatowitch M, Caron MG et al. J Biol Chem 264, 7564-7569 (1989).
19. Fredericks ZL, Pitcher JA and Lefkowitz RJ. J Biol Chem 271, 13796-13803 (1996).
20. Premont RT, Inglese J and Lefkowitz RJ. FASEB J 9, 175-182 (1995).
21. Kenakin TP and Morgan PH. Mol Pharmacol 1, 445-451 (1989).
22. Leff P. Trends Pharmacol Sci 9, 935-937 (1988).
23. Oksenberg D, Marsters SA, O'Dowd BF et al. Nature 360, 161-163 (1992).
24. Ansanay H, Sebben M, Bockaert J et al. Mol Pharmacol 42, 808-816 (1992).
25. Kaumann AJ and Sanders L. Naunyn-Schmiedeberg's Arch Pharmacol 349, 331-337 (1994).
26. Adhams N, Gerald C, Vaysse PJ-J et al. Soc Neurosci Abstr 21, 773 (1995).
27. Varrault A, Journot L, Audigier Y et al. Mol Pharmacol 41, 999-1007 (1992).
28. Cheng Y and Prussoff H. Biochem Pharmacol 22, 3099-3108 (1973).